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Cyclin D1 production in cycling cells depends on Ras in a 
cell-cycle-specific manner
Masahiro Hitomi and Dennis W. Stacey
Background: Cellular Ras and cyclin D1 are required at similar times of the cell
cycle in quiescent NIH3T3 cells that have been induced to proliferate, but not in
the case of cycling NIH3T3 cells. In asynchronous cultures, Ras activity has
been found to be required only during G2 phase to promote passage through
the entire upcoming cell cycle, whereas cyclin D1 is required through G1 phase
until DNA synthesis begins. To explain these results in molecular terms, we
propose a model whereby continuous cell cycle progression in NIH3T3 cells
requires cellular Ras activity to promote the synthesis of cyclin D1 during G2
phase. Cyclin D1 expression then continues through G1 phase independently
of Ras activity, and drives the G1–S phase transition.
Results: We found high levels of cyclin D1 expression during the G2, M and
G1 phases of the cell cycle in cycling NIH3T3 cells, using quantitative
fluorescent antibody measurements of individual cells. By microinjecting anti-
Ras antibody, we found that the induction of cyclin D1 expression beginning in
G2 phase was dependent on Ras activity. Consistent with our model, cyclin D1
expression during G1 phase was particularly stable following neutralization of
cellular Ras. Finally, ectopic expression of cyclin D1 largely overcame the
requirement for cellular Ras activity during the continuous proliferation of
cycling NIH3T3 cells. 
Conclusions: Ras-dependent induction of cyclin D1 expression beginning in
G2 phase is critical for continuous cell cycle progression in NIH3T3 cells. 
Background
The biological activities of cellular Ras and cyclin D1 are
often closely connected [1–5]. Ras responds to activated
growth factor receptors and is thus a growth-factor-sensi-
tive molecular switch within the cell [6,7]. Its activity is
transmitted through a cascade of kinases including Raf,
MEK and the mitogen-activated protein (MAP) kinase
Erk to induce the activity of transcription factors [8], some
of which are directly involved in inducing cyclin D1
expression [2,9–11]. Thus, by virtue of its induction by
Ras activity, cyclin D1 expression is directly responsive to
the extracellular growth factor environment [12]. Both cel-
lular Ras activity and cyclin D1 proteins are required for
the proliferation of most normal cell types. Cyclin D1
expression is induced to high levels when quiescent
NIH3T3 cells are stimulated to enter the cell cycle [13]. If
induction of cyclin D1 expression is blocked, or its activity
inhibited by anti-cyclin D1 antibodies, cell cycle progres-
sion is blocked [14,15], as is also observed when the cells
are treated with anti-Ras antibodies [16]. In cells released
from quiescence, Ras and cyclin D1 are both required
near the restriction point [17,18], the time at which
protein synthesis and growth factors cease to be required
for entry into S phase [19]. The restriction point is located
4–5 hours before the beginning of DNA synthesis in
NIH3T3 cells [18]. Most studies indicate that, upon entry
into S phase, the cell is committed to complete mitosis
[20], except under circumstances of unusual stress such as
DNA damage. 
The biochemical activity of cyclin D proteins is primarily
related to their ability to combine with cyclin-dependent
kinases (CDKs) 4 and 6, and to activate retinoblastoma
protein (Rb) kinase activity [21]. This action releases the
E2F transcription factor complex from inactivation by
hypophosphorylated Rb, and promotes the synthesis of a
variety of gene products directly involved in DNA synthe-
sis. The critical role of cyclin D as a modifier of the Rb
protein is demonstrated by the fact that it is dispensable in
Rb-negative cells [22,23]. High levels of cyclin D protein
shorten the length of G1 phase [1,15,24]. This might be
due to its ability to activate CDK4/6, or to its ability to
bind and thus inactivate CDK-inhibitory proteins, which
would otherwise block the activity of other cyclin–CDK
complexes [25]. Cyclin D1 expression has been reported
during the G1 phase of quiescent cells stimulated to enter
the cell cycle [26], and in the G2 phase of some tumor cells
[27]. Of the three members of the cyclin D family, cyclin
D1 is prominently expressed in NIH3T3 cells; other
cyclins are also expressed in this and other cell types.
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To determine the cell cycle requirement for Ras activity
and cyclin D1 in cycling NIH3T3 cells, we have previously
developed a time-lapse strategy to determine the effects of
antibody microinjection on cell cycle progression. The
results were unexpected as they were different to those pre-
viously described for quiescent cells [18]. Anti-cyclin D1
antibody was able to block entry into S phase even when
introduced just before the beginning of DNA synthesis.
Anti-Ras antibody, on the other hand, blocked entry into S
phase only when introduced several hours before the begin-
ning of DNA synthesis. Thus, in cycling NIH3T3 cells, Ras
activity appeared to be largely unnecessary soon after cells
had passed through mitosis [18]. This fact might indicate
that Ras induces a factor(s) in G2 phase whose expression
continues into G1 phase and is required for initiation of
DNA synthesis. The fact that cyclin D1 is required through
G1 phase, and typically is induced by cellular Ras activity
makes it an attractive candidate for such a factor. Here, we
have extended these observations. Experiments were
designed to test the possibility that Ras activity during G2
phase induces the expression of cyclin D1, which then con-
tinues through G1 phase in a Ras-independent manner, and
plays a critical role in promoting the G1–S phase transition.
The validation of this hypothesis is important for under-
standing the signaling interactions required for cell cycle
control in continuously proliferating cells.
Results
We postulated that, for cells to maintain active prolifera-
tion, growth factors must be present during G2 phase to
induce cellular Ras activity, which then leads to the eleva-
tion of cyclin D1 levels. Cyclin D1 is required for the
G1–S phase transition, so its expression must continue
through mitosis and G1 phase, even though its expression
becomes independent of Ras activity several hours before
the G1–S phase boundary. This model makes four sepa-
rate predictions which were tested here. First, cyclin D1
levels should be elevated before mitosis in rapidly cycling
cells. Second, the expression of cyclin D1 should depend
on Ras activity in all cell cycle phases. Third, once cycling
cells enter G1 phase, cyclin D1 levels should remain high
even in the absence of continued Ras activity. And fourth,
cyclin D1 should be a primary proliferative target of Ras
signaling, such that cyclin D1 plays a major role in promot-
ing the cell cycle progression of cycling NIH3T3 cells
even in the absence of continued cellular Ras activity. 
Time-lapse analysis of the expression of cyclin D1 during
G2 phase
As a direct test of the first prediction, the levels of cyclin
D1 in various cell cycle phases were determined using a
time-lapse procedure to eliminate the need for cell 
synchronization [18]. An asynchronous culture was fol-
lowed in time lapse for 20 hours, after which cells were
fixed and stained for cyclin D1. The level of cyclin D1-
associated fluorescence within the nuclear region was then
quantitated on a cell-by-cell basis with a microscope
equipped with a photomultiplier. From the time-lapse
movie, it was possible to determine the approximate cell
cycle position of an individual cell on the basis of its age
(the time since it had passed through mitosis before fixa-
tion). Previous studies demonstrated that cells less than
4 hours old would be in G1 phase, cells between 5 and
12 hours old would most likely be in S phase, whereas
cells greater than 12 hours old would begin entering G2
phase. The generation time of these cells is 16–18 hours
[18]. For the purposes of presentation, cells of a given age
were grouped together and the average fluorescence
values were determined and plotted against the age of the
group of cells (mean ± standard error). As expected, cyclin
D1 levels were high in G1 phase and fell rapidly soon after
the cells entered S phase. Significantly, after falling to low
levels during early S phase, cyclin D1 levels began to
increase as the cells progressed through S phase into G2
phase (Figure 1). 
Double-staining strategy to determine cyclin D1 levels
To confirm the results from time-lapse analysis, a digital
image analysis approach was used to determine cell cycle
position from the DNA content of individual cells. The
utility of this approach was first demonstrated by pulsing
an asynchronous NIH3T3 culture with bromodeoxyuri-
dine (BrdU) for 1 hour, followed by fixation and staining
of DNA with 4,6-diamidino-2-phenylindole (DAPI) and
the incorporated BrdU with a fluorescent antibody stain.
Separate digital images of each fluorochrome were taken
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Figure 1
Time-lapse analysis of cyclin D1 expression in proliferating cells. A
culture of cycling NIH3T3 cells was followed in time lapse for 20 h,
fixed and stained with a fluorescent anti-cyclin D1 stain. The total
amounts of fluorescence associated with the entire nuclear region of
individual cells was determined quantitatively using a microscope
equipped with a photomultiplier. The average fluorescence (cyclin D1
levels) of all cells of a given age is plotted (in arbitrary units ± SEM; the
levels in quiescent cells being regarded as zero) against the average
age of the cells. The approximate cell cycle position, on the basis of
previous work [18], is indicated above the graph.
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of identical areas of the coverslip with a charge-coupled
device (CCD) camera. The DAPI staining identified
nuclear regions in which the levels of both DAPI and anti-
BrdU antibody fluorescence were quantitated. When
DAPI fluorescence was plotted against BrdU-associated
fluorescence for individual cells, cells in G1 and G2
phases were localized in well-separated groups without
BrdU staining. S phase cells displayed intermediate DNA
levels, and stained for BrdU, with the highest levels of
staining found in cells in mid-S phase (Figure 2a). The
DAPI fluorescence determined by this method was pro-
portional to DNA content.
This quantitative immunofluorescence approach was used
to determine cyclin D1 expression levels of individual
cycling NIH3T3 cells. A rapidly proliferating culture was
stained for cyclin D1 by indirect immunofluorescence and
for DNA with DAPI. The nuclear fluorescence of individ-
ual cells was quantitated as above by digital image analy-
sis. The results were completely consistent with those
obtained by the time-lapse photomultiplier analysis. High
levels of cyclin D1 were present in cells with G1 phase or
G2 phase levels of DNA, but cyclin D1 levels were low in
cells with S phase levels of DNA (Figure 2b). Together,
these independent analyses confirm that cyclin D1 is
indeed elevated during the G2 phase of cycling cells, as
predicted by the model. In the time-lapse analysis, the
absolute amount of cyclin D1-associated fluorescence was
measured to obtain the total nuclear content of cyclin D1.
In the double-staining experiments, on the other hand, the
average fluorescence intensity was reported. In these cells,
the fluorescence intensity measurement accurately cor-
rects for the increase in size and DNA content of a cell as it
progresses through the cell cycle, and indicates the relative
cyclin D1 levels of cells in different cell cycle phases (see
Supplementary material). The dramatic increase in cyclin
D1 content as cells leave S phase and enter G2 phase was
clearly evident from both measurements. 
Confirmation of the antibody staining procedure
To demonstrate that the antibody staining procedure rec-
ognized only cyclin D1, analyses were performed on
fibroblasts from a cyclin D1 knock-out mouse embryo and
a wild-type littermate (generous gifts from Piotr Sicinski,
[28]). Cyclin D1+/+ mouse embryonic fibroblasts showed
the same cell cycle-dependent cyclin D1 expression
pattern as NIH3T3 cells. In cyclin D1–/– embryonic fibro-
blasts, on the other hand, only background levels of stain-
ing were observed regardless of the cell cycle phase (data
not shown). Moreover, the pattern of cyclin D1 expression
in NIH3T3 cells was also confirmed using a separate
monoclonal antibody (DCS-6, a generous gift of Michele
Pagano [14,18,29]). 
Next, as levels of cyclin D1 were observed by antibody
staining to be high in G2 and G1 phases, it followed that
these levels would also be high in mitotic cells. To
confirm this biochemically, M phase cells collected by
mitotic detachment were immediately lysed and the
cyclin D1 levels  determined by western blot analysis.
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Digital image analysis of cyclin D1 levels. (a) To test how reliably we
could quantitate fluorescence levels in individual cells using the CCD
camera, NIH3T3 cells were pulsed with BrdU for 1 h and fixed. DNA was
stained with DAPI, and the incorporated BrdU was detected by indirect
immunofluorescence. Separate fluorescence images of each
fluorochrome were collected with the CCD camera and the fluorescence
levels for individual cells determined by image analysis as described in
the Materials and methods. The results (in arbitrary units) for each cell
are plotted, with an indication of the position of BrdU-positive and
BrdU-negative cells. (b) The above procedure was used to determine
the levels of cyclin D1 throughout the cell cycle of cycling NIH3T3 cells.
Cells in an asynchronous culture were fixed and stained with a
fluorescent antibody stain against cyclin D1. The DNA was stained with
DAPI. The nuclear intensities of cyclin D1 are plotted against the total
DAPI staining for each cell analyzed. As an aid to interpretation, the same
data are presented but with notations of the cells in different cell cycle
stages (right). From these results, it is clear that the average cyclin D1
levels are high in cells in G1 and G2 phases, and low in S phase cells.
For comparison, the cyclin D1 levels were also deter-
mined in quiescent cells (in which cyclin D1 levels would
be low), and in these cells stimulated for 10 hours with
serum to induce high levels of cyclin D1 expression [18].
Mitotic cells contained even higher levels of cyclin D1
than stimulated NIH3T3 cells in late G1 phase
(Figure 3a). The cyclin D1 protein levels in mitotic cells
provide a direct biochemical confirmation of the staining
results reported above.
Finally, it is possible that intermolecular associations
might interfere with antibody binding to cyclin D1,
resulting in underestimates of its level within the cell,
even though the antibodies used for cyclin D1 staining
(clone 72-13G) in this study can recognize cyclin D1 in
an active protein complex [29–31]. To demonstrate
directly that antibody staining intensity is proportional to
cyclin D1 protein levels, both were determined in 
parallel cultures synchronized by serum deprivation
(Figure 3b). At various times after serum re-stimulation,
the levels of cyclin D1 determined in parallel cultures by
quantitative western blotting or by digital analysis were
compared. Cell cycle progression was monitored by
thymidine labeling in a third set of parallel cultures. The
fluorescence levels of cyclin D1 are presented as the
simple fluorescent intensity as above, or as the total
cyclin D1 fluorescence divided by the DNA content of
each cell. The amount of cyclin D1 protein determined
by western analysis was normalized to the levels of actin.
Results at each time point are presented as a percentage
of the maximum level (at 9 hours; Figure 3b). In each
case, the levels of cyclin D1 were low for 6 hours follow-
ing serum addition, increased to a maximum at 9 hours,
and fell off as cells entered S phase beginning 12 hours
after serum addition. This indicates that cyclin-D1-asso-
ciated fluorescence intensity determined by the analysis
of immunofluorescence faithfully represents the amount
of cyclin D1 protein as determined by quantitative
western blotting. 
Dependence of cyclin D1 expression on endogenous Ras
activity
Microinjection of neutralizing anti-Ras antibody followed
by the double-staining strategy provided a means to test
the second and third predictions of the model: that cyclin
D1 expression is dependent on Ras, and that expression
during G1 phase is relatively stable following removal of
Ras activity. At various times after microinjection of anti-
Ras antibody, cells were pulsed with tritiated thymidine
for 1 hour and fixed. The cells were then stained for DNA
with DAPI, and with separate antibodies against cyclin D1
and against the injected immunoglobulin (to identify
injected cells). The cell cycle expression of cyclin D1 was
determined using a microscopic photomultiplier by com-
paring its fluorescent intensity to total DNA-associated
fluorescence; with thymidine-labeled and unlabeled cells
noted from autoradiography. Although the method of
determining fluorescence levels differed from that
described above with the CCD camera, the overall
approach was similar, and absolutely no differences were
observed between results with the CCD camera (Figure
2b) and those obtained with the microscopic photomulti-
plier (Figure 4, 0 hours).
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Figure 3
Biochemical determination of cyclin D1 levels. (a) Mitotic cells (M)
were collected from a cycling NIH3T3 culture by mechanical
detachment and lysed. For comparison, lysates were prepared of
quiescent cells (G0) and of quiescent cells 10 h after stimulation
with serum. The amount of cyclin D1 is maximal around 9 h after
serum stimulation of quiescent cells, as shown in (b). Equal amounts
of protein were electrophoresed and subjected to western blotting
with an anti-cyclin D1 antibody. As a control for loading, the amount
of actin on the blot was also determined by western blotting.
(b) Quiescent NIH3T3 cells were stimulated with serum and, after
the indicated times, cells were harvested and analyzed by
quantitative western blotting. Cyclin D1 levels were normalized to
actin content (open squares), and the numbers reported as the
percentage of the maximal signal at 9 h. A second set of parallel
cultures were also fixed and stained for DNA and cyclin D1. The
nuclear fluorescence associated with both stains was determined on
a cell-by-cell basis by image analysis. The mean values (350–450
cells) of the fluorescence intensity of cyclin D1 (open circles), or the
total cyclin D1 fluorescence normalized to DNA content (closed
circles) are plotted. The error bars indicate standard errors. To
monitor the G1–S transition, cells from a set of parallel cultures were
labeled with tritiated thymidine soon after the serum addition. They
were fixed at the indicated times, and the proportion of thymidine-
labeled nuclei determined by autoradiography (triangles). It is clear
from this analysis that the image analysis of stained cells accurately
reflects the total amount of cyclin D1 in the culture as determined by
western analysis.
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As predicted, cyclin D1 levels in all cell cycle phases were
strictly dependent on cellular Ras activity (Figure 4,
24 hours). Significantly, however, the rate at which the
levels of cyclin D1 declined following anti-Ras antibody
injection differed. At 6 hours after anti-Ras antibody injec-
tion, cyclin D1 levels in G1 phase cells remained high, but
were reduced to low levels in most cells in G2 phase. By
12 hours after injection, cyclin D1 levels in G1 phase cells
had also declined to low levels (Figure 4). After 24 hours,
most cells were in G1 phase, but the few cells remaining
in S and G2 phases expressed extremely low levels of
cyclin D1 (Figure 4). A control injection of non-immune
rat immunoglobulin G had no effect on cyclin D1 expres-
sion levels (data not shown). It is important to note that
the cyclin D1 levels of all cells 24 hours after anti-Ras
antibody injection were uniformly lower than even the S
phase cells in the control (0 hours) culture. This means
that, even in S phase cells, endogenous Ras activity results
in the production of measurable levels of nuclear cyclin
D1 protein. 
It is possible that the injected anti-Ras antibody had
functioned primarily by blocking the activation of cellular
Ras during the transition between cell cycle phases,
rather than by directly inhibiting the activity of Ras pro-
teins that were already activated and therefore bound to
effector molecules. To address this possibility, time-
course analyses as above were performed in NIH3T3
cells transformed by a Ras mutant, Val12 Ras, which has a
low intrinsic GTPase activity that is not enhanced by
GTPase-activating proteins. A high proportion of these
molecules would, therefore, be expected to be activated
and thus bound to effector molecules throughout the cell
cycle. In these transformed cells, however, the results
were similar to those described above, with approxi-
mately 6 hours required to reduce the levels of cyclin D1
in G2 phase cells, and approximately 12 hours required to
reduce levels in G1 phase cells (data not shown). The
kinetics of suppression of cyclin D1 levels following anti-
Ras antibody injection must, therefore, reflect the neu-
tralization of all Ras protein within the cell, regardless of
the state of activation. 
The above time-course analyses support the predictions
of the model and indicate that cyclin D1 expression is
induced in a Ras-dependent manner as cells pass from S
to G2 phase and that, once induced, cyclin D1 expres-
sion in G2 phase continues through G1 phase indepen-
dently of Ras. It is critical, however, to perform separate
experiments designed to specifically validate each of
these important conclusions. A time-lapse analysis was
first used to demonstrate directly that, when anti-Ras
antibody is microinjected during G2 phase, the levels of
cyclin D1 remain high into the next G1 phase. Cells
were followed in time lapse for 18 hours before injection
of anti-Ras antibody, and for an additional 6 hours there-
after. The cells were then fixed and stained for DNA,
the injected immunoglobulin, and cyclin D1. This
approach allows the direct identification of cells microin-
jected during G2 phase, and follows them into G1 phase.
Cells that had passed through mitosis between anti-Ras
antibody injection and the termination of the experiment
would have been in G2 phase at the time of injection,
but would generally be in G1 phase at the time of 
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Ras dependence of cyclin D1 expression throughout the cell cycle.
Anti-Ras antibody was injected into cells on several plates. At the
indicated times after injection, the cells received a 1 h pulse of
thymidine, were fixed and stained for cyclin D1, for injected
immunoglobulin, and for DNA with DAPI. The fluorescence intensity of
the cyclin D1-associated fluorochrome in the nuclear region of injected
cells was determined on a cell-by-cell basis with a microscope
equipped with a photomultiplier. The total DNA content was also
determined in separate photomultiplier analyses. As in Figure 2, the
fluorescence levels of cyclin D1 were plotted against the total amounts
of DNA-associated fluorescence for each cell analyzed. The results for
thymidine-labeled (closed circles) and unlabeled (open circles) cells are
noted. The levels of cyclin D1 in G2 phase cells was dramatically
reduced within 6 h following injection of anti-Ras antibody, whereas the
levels in G1 phase cells required 12 h for efficient suppression. By 24 h
after anti-Ras antibody injection, cyclin D1 levels had been reduced to
the lowest levels observed. Only injected cells, as identified by staining
for the injected immunoglobulin, were considered in this analysis.
fixation. In such cells, the levels of cyclin D1 were indis-
tinguishable from their uninjected neighboring cells in
the same cell cycle position (Figure 5a). Clearly, anti-Ras
antibody injection during G2 phase had not significantly
reduced cyclin D1 expression in the subsequent G1
phase. On the other hand, the cyclin D1 levels of cells
that did not pass through mitosis following injection of
anti-Ras antibody  was reduced in this experiment.
These cells would have been in G1 or S phase at the
time of injection and would have passed into S or G2
phase before fixation. In these cells, the anti-Ras anti-
body had apparently blocked the induction of cyclin D1
expression (Figure 5a). 
The second conclusion, that anti-Ras antibody had
blocked the induction of cyclin D1 as cells passed from
S to G2 phase could only be estimated from the above
time-lapse analysis, as it is not easy to distinguish between
cells in S and G2 phases in time-lapse analyses. Therefore,
an independent labeling study was performed. NIH3T3
cells in an asynchronous culture were injected with anti-
Ras antibody and then immediately pulsed with BrdU for
1 hour, then chased without BrdU for an additional
7 hours, and finally pulsed with tritiated thymidine for the
final hour before fixation and staining as above. Parallel
injections of non-specific rat immunoglobulin provided a
control. We paid particular attention to injected cells that
were labeled with BrdU but not with thymidine. These
cells must have passed from S to G2 phase following injec-
tion. As predicted, the cyclin D1 levels in these cells were
low following injection of anti-Ras antibody compared
with such cells injected with control immunoglobulin
(Figure 5b). This result directly demonstrates the require-
ment for Ras during the S–G2 phase transition period for
efficient induction of cyclin D1 expression. Taken
together, the above experiments provide strong support
for the predictions of the model relating to cell cycle
expression of cyclin D1.
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The two approaches used to determine whether Ras activity is
required for cyclin D1 expression during transitions between cell
cycle phases. (a) Cells were followed in time lapse for 18 h before
injection of anti-Ras antibody, and then for an additional 6 h after
injection; the cells were then fixed and stained for cyclin D1
expression. The age of the cells at the end of the experiment is
indicated; the age at the time of injection would be 6 h earlier. The
approximate cell cycle positions at the time of injection and at the
end of the experiment are indicated above the graph. Cells less than
6 h old at the end of the experiment must have divided between
injection and fixation, and would therefore have passed from G2 to
G1 phase during the analysis. Cells 6–14 h old would most probably
have passed from G1 to S phase following antibody injection, while
cells older than 14 h would probably have passed from S to G2
phase following injection. Cyclin D1 levels are expressed in arbitrary
units, with background readings set at zero. In parallel experiments,
no difference was observed between cells injected with a control
immunoglobulin and uninjected cells. (b) The next analysis was
designed to identify specifically cells passing from S to G2 phase
following anti-Ras antibody injection. Cells were pulsed with BrdU for
1 h immediately after injection of anti-Ras antibody, and with tritiated
thymidine for 1 h beginning 8 h after that injection. Following fixation,
the cells were stained for DNA with DAPI, and for BrdU, injected
immunoglobulin and cyclin D1 with antibodies linked to separate
fluorochromes. Finally, the incorporation of thymidine was determined
by autoradiography (see Materials and methods). As a control,
parallel injections of a non-specific rat immunoglobulin were
performed and analyzed identically (closed circles). For the purposes
of this analysis, only injected cells that were BrdU-positive and
thymidine-negative were considered. This would ensure that the cells
had passed from S to G2 phase following injection. The cyclin D1
levels of such cells are plotted against their DNA content. It is clear
that the injected anti-Ras antibody had efficiently blocked induction of
cyclin D1 in these cells.
Forced expression of cyclin D1 substitutes for Ras activity
in cycling cells
The final prediction of the model suggests that Ras activ-
ity is unnecessary in the G1 phase of cycling cells because,
by the time cells enter this cell cycle phase, the produc-
tion of cyclin D1 has become Ras-independent. This sug-
gests that, to a certain extent, the cell cycle function of
Ras is accomplished upon the stable induction of cyclin
D1. If this is true, forced expression of cyclin D1 would be
expected to promote proliferation, at least in part, even in
the absence of cellular Ras activity in cycling cells. 
To test this possibility, NIH3T3 cells were stably trans-
fected with a plasmid expressing the human cyclin D1
gene driven by the cytomegalovirus (CMV) promoter [32].
Two such clones were tested (D7 and D33). Careful
analyses demonstrated that the production of human
cyclin D1 in these cells was at nearly the same level as the
production of cyclin D1 in human diploid fibroblast
MRC5 cells. Anti-Ras antibody was injected into both
clones of human cyclin-D1-expressing cells, as well as into
parental NIH3T3 cells. The level of proliferation in
injected cells was determined with a 1 hour pulse of
thymidine at 24 hours after injection. Injected cells were
positively identified by immunofluorescence staining for
the injected immunoglobulin. Although the anti-Ras anti-
body suppressed thymidine labeling, and therefore prolif-
eration in NIH3T3 cells by 90%, the proliferation of cells
expressing the exogenous cyclin D1 was suppressed by
only 40% (Figure 6). As a control, anti-cyclin D1 antibody
was also injected into all three cell types and shown to
reduce proliferation in all three similarly and efficiently
(Figure 6). Finally, independent experiments demon-
strated that injection of anti-Ras antibody into the two
clones expressing exogenous cyclin D1 did not suppress
expression of this transgene (data not shown). 
Discussion
Cyclin D1 plays a critical role in the control of cell prolif-
eration. It is an important target of cellular Ras activity, is
expressed at elevated levels in a number of tumor types
[33], particularly in those tumors with activated ras genes
[1,3,34], and constitutes an Rb kinase which is essential to
cell cycle progression [14]. Cyclin D1 expression is low in
quiescent cells, but is stimulated following serum addition
to high levels at the time the cells pass the restriction
point and become committed to enter S phase several
hours later [14,19]. Little information, however, is known
about the role of cyclin D1 in controlling the proliferation
of continuously cycling cells. This question was addressed
in a time-lapse analysis of asynchronous NIH3T3 cells
injected with anti-cyclin D1 antibody. Cyclin D1 activity
was found to be required throughout G1 phase until the
beginning of DNA synthesis. On the other hand, cellular
Ras activity was required to a minimal extent during G1
phase, but was necessary during the preceding G2 phase
[18]. To explain these differences in the cell cycle
requirements for Ras and cyclin D1, we propose that
growth factors and other conditions conducive to contin-
ued proliferation must be available to rapidly cycling cells
before mitosis, if the cell is to avoid quiescence and
proceed through the next cell cycle. The growth factors
stimulate Ras activity during G2 phase, resulting in the
production of molecules required for cell cycle progres-
sion. The expression of these molecules becomes inde-
pendent of Ras activity following passage through mitosis,
and remains active until S phase begins. Because cyclin
D1 is required through G1 phase, and because cyclin D1
is known to be a critical target of Ras activity in the control
of proliferation, we predicted that cyclin D1 is one of the
primary targets of cellular Ras activity induced in G2
phase and whose activity continues through G1 phase to
promote entry into S phase (Figure 7). This possibility led
to the four predictions tested in this study.
First, several independent experimental approaches were
used to demonstrate that cyclin D1 is expressed to high
levels in the nuclei of cells in G2 phase. Second, cellular
Ras activity was necessary for the expression of cyclin D1
in all cell cycle phases. Third, upon neutralization of cel-
lular Ras activity with injected anti-Ras antibody, the
high level expression of cyclin D1 in G2 and G1 phases
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Figure 6
Exogenous expression of cyclin D1 reduces the requirement for
cellular Ras. Two NIH3T3 cell lines (D7 and D33) expressing the
human cyclin D1 gene controlled by the CMV promoter, together with
parental NIH3T3 cells for comparison, received injections of anti-Ras
and anti-cyclin D1 antibodies. The injected cells were cultured for
23 h, pulsed with labeled thymidine for 1 h, fixed and
autoradiographed. The proportion of injected cells (as identified by
staining with a fluorescent antibody against the injected
immunoglobulin) that were labeled with thymidine (normalized against
the labeling of surrounding uninjected cells) is plotted for each
injection. Any cell in S phase 24 h following antibody injection would
have escaped cell cycle inhibition. Whereas anti-cyclin D1 antibody
efficiently inhibited cell cycle progression in all cells, the anti-Ras
antibody was poorly inhibitory for the cyclin-D1-expressing cells. The
results are from three separate experiments.
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continued for several hours. The expression of nuclear
cyclin D1 in G1 phase was most stable, requiring more
than 6 hours following injection of anti-Ras antibody for
reduction to be observed. Separate analyses directly
demonstrated that cyclin D1 levels are induced in a Ras-
dependent manner as cells pass from S to G2 phase, and
that, once induced in G2 phase, cyclin D1 levels remain
high during G1 phase even in the absence of Ras activity.
These results provide critical support for the model
which predicts that Ras activity in G2 phase induces the
stable expression of cyclin D1 until the beginning of the
next S phase. 
The means by which cellular Ras might stabilize cyclin
D1 synthesis is not known, but several possibilities exist.
Ras may regulate cyclin D1 stability by controlling the
activity of signaling molecules able to phosphorylate a crit-
ical residue that controls the rate of proteasomal degrada-
tion [35]. In addition, the stability of cyclin D1 is
regulated by direct degradation by calpain protease [36].
In any case, the half life of cyclin D1 is quite short, from
12–60 minutes depending on the signaling environment
within the cell [35,37]. It would appear unlikely, there-
fore, that changes in protein stability alone could account
for the above results [11,35]. Finally, it is generally
believed that cyclin D1 must be localized in the nucleus
to be active. We have focused throughout these studies on
nuclear levels of this protein. It is also possible that the
control over nuclear localization might also have a role in
its cell cycle regulation [38], although preliminary studies
revealed no evidence for the shuttling of cyclin D1 protein
between nucleus and cytoplasm during the cell cycle of
NIH3T3 cells (see Supplementary material).
Finally, the model makes a fourth prediction tested in this
study, that a primary function of Ras activity in cycling
cells is the induction of cyclin D1. This suggests that
ectopic expression of cyclin D1 might overcome, to some
extent, the requirement for cellular Ras during prolifera-
tion. To test this prediction, cells expressing human cyclin
D1 from a viral promoter were analyzed. In these cycling
cells, anti-Ras antibody was a poor inhibitor of prolifera-
tion, whereas anti-cyclin D1 antibody inhibited efficiently.
Although this is the only observation in our studies that
supports a role for cyclin D1 as a critical proliferative target
of Ras activity, a number of other reports also support this
idea [4,9,39]. Taken together, these results, along with a
number of others that emphasize the role of cyclin D1 in
control of proliferation, provide support for the idea that
cyclin D1 has the ability to promote entry into S phase,
independently of Ras activity, as predicted. 
Taken together, these results strongly support all four pre-
dictions of the model, which postulates that the growth
conditions necessary for continued cell cycle progression
must be sensed during late stages of the cell cycle, leading
to the induction of Ras activity together with the targets of
this activity, including cyclin D1. Once induced during G2
phase in a Ras-dependent manner, cyclin D1 continues to
be expressed through mitosis and G1 phase even in the
absence of Ras activity. Cyclin D1 performs a vital func-
tion during the G1–S phase transition as evidenced by the
fact that it can substitute for the proliferative requirement
for Ras to some extent. Thus, cellular Ras activity is not
required during the G1 phase in cycling cells, whereas
cyclin D1 activity is required throughout G1 phase. These
interactions between two molecules known to be vital for
the control of proliferation apparently play a critical role in
the control of continued cell cycle progression. It will be
interesting in future studies to determine the role of other
cell cycle control molecules, such as cyclin-inhibitory mol-
ecules, together with Ras and cyclin D1 in the control of
cell cycle progression.
Materials and methods 
Time-lapse video photography 
Antibody preparation, cell culture, image capture and autoradiography
were performed as described [18]. When cyclin D1 expression was
assessed following time-lapse analysis and antibody injection, the cells
were fixed and stained immediately following the final time-lapse frame.
The staining characteristics of cells as determined by CCD or micro-
scopic photomultiplier analysis were then combined with the analysis
of cell age. 
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Figure 7
Schematic illustration of the model supported by this work. The cell cycle
is represented as a circle with mitosis (M) at the top and the approximate
positions of other cell cycle phases indicated, together with G1–S phase
transition and the points in the cell cycle at which anti-Ras and anti-cyclin
D1 antibodies lose their abilities to block entry into S phase. The
approximate cell cycle positions of nuclear cyclin D1 accumulation and
DNA synthesis are indicated. As illustrated, growth factors stimulate Ras
activity, which promotes cyclin D1 expression during G2 phase. Cyclin
D1 is then continuously expressed through mitosis and G1 phase to
promote passage through the G1–S transition.
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Measurement of fluorescent signal of each stained cell
For the quantitative fluorescence microscopy, the narrow band-pass
filter cubes for DAPI, Cy2, Cy3 and Cy5 were used to minimize the
cross-over signal reading among fluorochromes. The fluorescence
intensity was determined by two separate devices, a photomultiplier
(Leitz) or a cooled CCD camera (Princeton Instruments). Measure-
ments with the photomultiplier were performed on a cell-by-cell basis.
Digital images were captured using a cooled CCD camera controlled
with Metamorph software (Universal Imaging). The exposure time was
adjusted so that the brightest signal in the specimen gave less than
90% of the maximum linear exposure for the camera. The DAPI-stained
image was thresholded to generate a binary mask which included each
nucleus. With this mask, the intensity and total fluorescence of each
individual nucleus in images of each fluorochrome were obtained.
Shading corrections were used to adjust for uneven illumination.
Careful analyses which failed to demonstrate translocation of cyclin D1
from the nucleus to the cytoplasm are described in Supplementary
material. In addition, evidence that the size of the nucleus increases
proportionally to DNA content is also presented in Supplementary
material. This fact makes it possible to determine cyclin D1 content rel-
ative to cell cycle phase by measuring fluorescence intensity.
In Figure 5b, it was necessary to quantitate the fluorescence levels of
four separate fluorochromes for each cell. Cells were first stained for
cyclin D1 and injected IgG as described [18]. Then, after re-fixation
with 70% ethanol in 50 mM glycine-HCl, pH 2.0 (–20°C), BrdU was
stained with sheep anti-BrdU antibody following partial digestion of
DNA (EcoRI and exonuclease III) [40], followed by incubation with
Cy5-conjugated anti-sheep IgG. DNA was stained with DAPI.
Mitotic shake-off and western blotting
Cell culture plates of rapidly growing NIH3T3 cells were mechanically
vibrated to detach mitotic cells. Only when greater than 85% of the
detached cells displayed condensed chromatin were the cells used for
determination of cyclin D1 content by western blotting [13]. To quantitate
the immunoreactive bands, the blot was developed with chemifluores-
cence substrate (Amersham) after incubating with an alkaline-phos-
phatase-conjugated secondary antibody. The blot was scanned with
Storm Imager 840 and the band intensity was determined by Image
Quant software (Molecular Dynamics). Integrated cyclin D1 intensity was
normalized to the corresponding actin band on the same blot. 
Supplementary material
Additional methodological details are available at http://current-
biology.com/supmat/supmatin.htm.
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Supplementary materials and methods
Materials
Autoradiography emulsion type NTB2 was obtained from Eastman
Kodak Company. DAPI was a product of Molecular Probes. Cy3-con-
jugated-anti-rat IgG, Cy2-conjugated-anti-rat IgG with minimal cross-
reactivity against mouse IgG, Cy3-conjugated-anti-mouse IgG,
Cy3-conjugated-anti-mouse IgG with minimal crossreactivity against
rat IgG, and Cy5-conjugated-anti-sheep IgG were purchased from
Jackson ImmunoResearch. Sheep polyclonal anti-BrdU antibody was
a product of Fitzgerald Industries International. Anti-mouse-cyclin D1
(72-13G) was purchased from Santa Cruz Biotechnology. Anti-
human-cyclin D1 (ZY-7D2) was a product of Zymed Laboratories
Inc. Anti-actin mouse monoclonal antibody (clone C4), horseradish-
peroxidase-conjugated and alkaline-phosphatase-conjugated anti-
mouse IgG, and EcoRI were obtained from Boehringer Mannheim.
Exonuclease III, [methyl-3H]thymidine (80 Ci/mmol) and ECF
(enzyme chemifluorescence) detection module were purchased from
Amersham.
Time-lapse video photography 
Antibody preparation, cell culture and autoradiography were performed
as described [S1]. Digital images were obtained with a CCD camera
(Sony) attached to a frame-capture board controlled by the NIH Image
program [S1]. The area of the coverslip to be analyzed was marked
with two contiguous circles of varying size using a diamond object
marker (Leitz). This allowed realignment of the area of analysis and
identification of individual cells following immunostaining, DAPI staining
and/or autoradiography. In this approach, the cells were illuminated
continuously with low-level green light. 
To avoid possible complications with this constant illumination, several
experiments were duplicated with a similar approach except that the
light was shuttered. In this case, the cells were illuminated only during
the time of exposure, less than 1 sec every 10 min. These images were
collected with a highly sensitive, cooled CCD camera (Princeton Instru-
ment) and controlled by the Metamorph software package (Universal
Imaging). Because of the sensitivity of the cooled CCD camera, the
cells were illuminated with extremely faint light. In these cases, there is
little possibility that the illumination of cells would have any effects on
the results obtained. In no case were the results with the two methods
of illumination different. 
When a second time-lapse analysis followed microinjection, care
was taken to ensure that the same area of the coverslip and the
same alignment were viewed in each movie. Antibodies to be studied
were microinjected into all the cells, and only the cells, within the
designated circular area. In this way, it was possible to follow the
analysis from the beginning and determine which cells had arisen
from originally injected cells. The injection was further confirmed by
immunofluorescence staining for injected antibody. Immunofluores-
cence staining and detection of DNA synthesis were performed as
described [S1]. When cyclin D1 expression was assessed following
time-lapse analysis and antibody injection, the cells were fixed and
stained immediately following the final time-lapse frame. The staining
characteristics of cells, as determined by CCD analysis, were then
combined with the analysis of cell age. It should be noted that, in
such an analysis, the cell age is calculated from the end of the exper-
iment (Figure 5 in the paper). As the analysis was terminated 6 h fol-
lowing anti-Ras antibody injection, the age at the time of injection
can also be determined.
Measurement of fluorescent signal of each stained cell
A Leica fluorescent microscope DM 900 was used to quantitate fluo-
rescence intensity. The Leica filter cubes, cube A, cube L4, cube
N2.1, and a cube #41008 Cy5 from Chroma Technology were used
to detect signal from DAPI, Cy2, Cy3, and Cy5, respectively. With
these cubes, no significant crossover signal was detected except the
faint crossover of Cy5 signal to the Cy3 cube (see below). We used
two different devices for quantitation, a photomultiplier and a cooled
CCD camera. 
Photomultiplier (Leitz) readings were controlled by the software
program, Scope 5 (Kinetek Co.), with settings gain = 1, voltage = 500
and expose = 0.5 sec. The area of measurement was defined so that it
was large enough to include the entire nucleus (for total nuclear mea-
surement), or small enough to fit inside the nucleus (for nuclear density
measurement). Before photomultiplier measurement, a phase-con-
trasted photo of the field of interest was taken. As we measure the fluo-
rescence intensity, each cell was given an identification number on this
photo. In this way the fluorescence measurements could be related
back to individual cells in the time-lapse movie, or in the autoradiogram.
Thus, all the parameters for a given cell could be defined (the time of
mitosis determined by the movie, the photomultiplier value for cyclin
D1-associated fluorescence and the labeling status obtained after
autoradiography). 
Digital images were captured using a cooled (–25°C) CCD camera
(Princeton Instrument) controlled with Metamorph software. The expo-
sure time was adjusted so that the brightest signal in the specimen
gave less than 90% of the maximum linear exposure for the camera (a
gray scale of 0–4096, 12 bit gray scale). Integration of the fluores-
cence signal from each nucleus was obtained by processing the image
as described below using Metamorph analysis features. Each captured
image was corrected by subtracting the background image followed by
shading correction (to correct for the uneven signal collection across
the field). Both of the correction images were taken with the same
exposure time as the image to be corrected. The background image
was taken without a fluorescent specimen while the shading images
were collected from a specimen with uniform fluorescence. This was
achieved for Cy2 and Cy3 with a blank cover slip mounted with auto-
fluorescent nail polish (Ultra Hard Strengthened, Avon) taken with cube
L4 and cube N2.1, respectively. The shading image for DAPI was the
image of a blank coverslip mounted with the mixture of anti-fade mount-
ing media, Slowfade component A (Molecular Probes) and DAPI. This
mixture gave moderate fluorescence detectable with cube A. The
shaded image of the DNA fluorescence (taken with DAPI) was used to
make a mask with which to measure nuclear fluorescence with each
fluorochrome. This image was thresholded to generate a binary mask
which included each nucleus. With this mask the intensity and total flu-
orescence of each individual nucleus in images of each fluorochrome
were obtained. Thus, the fluorescence properties with each fluo-
rochrome for each nucleus was obtained. 
In Figure 5b in the paper, it was necessary to quantitate the fluores-
cence levels of four separate fluorochromes for each cell. The injected
immunoglobulin (Y13-259, a rat monoclonal antibody, or non-immune
rat IgG from Sigma) was stained with a Cy2-conjugated anti-rat IgG
antibody as a marker of injection; cyclin D1 was stained with a mouse
monoclonal followed by Cy3-conjugated anti-mouse IgG antibody as
described [S1]. Then, after re-fixation with 70% ethanol in 50 mM
glycine-HCl, pH 2.0 (–20°C), incorporated BrdU was stained with
Supplementary material
sheep anti-BrdU antibody with partial digestion of DNA (EcoRI and
exonuclease III), followed by Cy5-conjugated anti-sheep IgG antibody
[S2]. DNA was stained with DAPI. Fluorescence cubes specific for
each fluorochrome as described above were used. Very slight fluores-
cence crossover was detected only from the Cy5 fluorochrome to the
Cy3 filter. Therefore, the staining of BrdU with the Cy5 fluorochrome
was purposely rendered extremely faint. This still allowed identification
of BrdU-positive cells, but did not effect the strong staining of the
cyclin D1 with the Cy3-conjugated antibody.
Analytical considerations
As the cell progresses through the cell cycle, the nucleus increases in
DNA content and in size. An increase in content of a nuclear protein
through the cell cycle, therefore, might simply reflect the increase in the
DNA content. This increase, however, would only result in at most a
twofold increase in the content of a nuclear protein, and could not
account for the dramatic increases in cyclin D1 protein seen here as
cells progress from S- to G2-phases (Figure 2). Nevertheless, mea-
surements were performed to determine the average intensity of fluo-
rescence over the nucleus, rather than the total nuclear fluorescence,
to correct for the increase in DNA content through the cell cycle. With
this measurement, the cyclin D1 levels of S-phase cells were low com-
pared with cells in G1 or G2 phases, but the levels of fluorescence of
G1-phase cells compared with G2-phase cells was similar (Figure 3).
To determine how well this measurement corrected for the increase in
DNA content of the cell, the average volume of nuclei was compared
with the average DNA content. For these cells, this was a strictly linear
relationship, except for cells just before, during, or just following
mitosis. Therefore, the fluorescence-intensity measurements for inter-
phase cells accurately corrects for the increase in DNA content of the
cell and reveals differences in the relative cyclin D1 content. To ensure
that this was the correct conclusion, however, average fluorescence-
intensity measurements were performed with both the photomultiplier
(Figure 4) and with the CCD-captured image through software calcula-
tions (Figure 2). In this case, the window of the photomultiplier was
extremely small, and measurements were performed at high magnifica-
tion (40 ×) to ensure that the entire area being measured was localized
within the nucleus. In these cells, measurement of the DNA content
required a separate measurement with a window large enough to
include the entire nucleus as it was necessary to measure the total
DNA content of the nucleus for cell-cycle localization. In both types of
measurements, the nuclear intensity as determined by completely dif-
ferent procedures yielded highly similar results, which together confirm
the elevation of cyclin D1 in G2 phase even when the increase in size
and DNA content were taken into consideration (Figure 2).
In other studies, the nuclear levels of cyclin D1 were found to be critical
for the biological activity of cyclin D1 [S3]. It is possible that the
appearance of cyclin D1 in the nucleus might reflect a redistribution of
pre-existing cytoplasmic cyclin D1, rather than the de novo synthesis of
the protein [S4]. To ensure that only active cyclin D1 was measured,
only nuclear measurements are reported in this study. The possibility
that an increase in nuclear cyclin D1 might result from cellular redistrib-
ution, however, does reflect directly on our biochemical measurements
of total cellular cyclin D1 levels in mitotic cells (Figure 4). If significant
cellular redistribution of cyclin D1 takes place, the high content of this
protein in mitotic cells might not be informative. Should subcellular
redistribution contribute to the observed changes in nuclear cyclin D1
levels, the cytoplasmic staining level should be high during S phase
and low in G1 and G2 phases. Cells were stained with anti-cyclin D1
antibody and with DAPI. From CCD images, the nuclear fluorescence
intensity and total fluorescence levels were determined for both fluo-
rochromes, together with measurements of the cyclin-D1-associated
fluorescent intensity of typical cytoplasmic regions of each cell. When
the cytoplasmic cyclin D1 intensity was plotted against DNA content of
the cells, the cytoplasmic cyclin D1 levels stayed constant through the
cell cycle, or might have actually increased as cells entered G2 phase.
Only in mitotic cells, where cyclin D1 seemed to be excluded from con-
densed chromosomes, was the cytoplasmic signal high. Soon after
mitosis, the protein returned to the newly formed nuclei. It is concluded
that, within the limits of these analyses, the loss of nuclear cyclin D1 in
these NIH3T3 cells results primarily from the disappearance of cyclin
D1 from the cell. We, therefore, conclude that the levels of cyclin D1
we observed to be present in mitotic shakeoff cells required the pro-
duction of cyclin D1 during G2 phase. Moreover, the levels of cyclin
D1 in mitotic cells was higher than observed at any time following
serum stimulation of quiescent cells, further substantiating the de novo
production of cyclin D1 during G2 phase.
Mitotic shakeoff and western blotting
NIH3T3 cells in a 15 cm plates were mechanically vibrated in a repro-
ducible manner every 90 min. The medium from the plate was collected
and the detached cells were pelleted by centrifugation at low speed.
Pre-warmed medium was immediately added to each plate. The pel-
leted cells were suspended in 1 ml medium and a small number spread
on a slide together with ethanol:acetic acid (3:1). The plate was dried
and the chromatin stained with crystal violet. Only when greater than
85% of the detached cells displayed condensed chromatin were the
cells used for determination of cyclin D1 content by western blotting
[S5]. To quantitate the immunoreactive bands, the blot was developed
with Chemifluorescence substrate after incubating with an alkaline-
phosphatase-conjugated secondary antibody. The blot was scanned
with Storm 840 and the band intensity was determined by a software,
Image Quant (Molecular Dynamics). Integrated cyclin D1 intensity was
normalized to the corresponding actin band on the same blot. 
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